CA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


CA Cancer J Clin 1961; 11:82-87
doi: 10.3322/canjclin.11.3.82
© 1961 American Cancer Society
This Article
Right arrow Full Text (PDF) Freely available
Right arrow Submit a letter to the editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gilbertsen, V. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gilbertsen, V. A.

CA: A Cancer Journal for Clinicians, Vol 11, 82-87, Copyright © 1961 by American Cancer Society


A Plea for Improvement of the Results of Bowel Cancer Therapy

Victor A. Gilbertsen M.D.1

1 Assistant Professor, Department of Surgery, and Director, Cancer Detection Center, University of Minnesota, Minneapolis, Minnesota.

The opportunity would appear to exist to double or triple the survival rate for patients with cancer of the bowel—even without revising basic operative procedures and without having to do more radical primary surgery. Accomplishment of this goal, however, necessitates that patients and physicians alike be educated to the early symptoms of cancer of the bowel and that treatment be employed before lesions become further advanced.

More ideal, of course, would be the detection of asymptomatic cancer by routine periodic examination. Potentially, the magnitude of improvement in over-all survival rates would appear to be phenomenal. Reliable evidence exists, for example, that annual proctoscopic examination (followed by removal of any adenomatous polyps found) could almost completely prevent the development of all but the earliest, most favorably treated rectal malignancies and reduce the over-all "failure rate" (presently 70-80%) to 1/10-1/20 of the present figure.

This, then, is a plea for a realistic recognition: that the current results of treatment of cancer of the bowel are poor; that the usual patient is not salvaged, because operations usually employed are effective for "early" lesions rather than "average" lesions; and that treatment of patients, while they yet have either no symptoms or symptoms of short duration, likely will allow many of those patients to be salvaged who are now seemingly destined to die because of ignorance.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1961 by American Cancer Society.